Advertisement

Supply Chain



New York City-based Pfizer and Russia-based NovaMedica completed a long-term strategic partnership to transfer the rights and technologies for the production of more than 30 drugs from Pfizer's to NovaMedica's portfolio.

The U.S. Food and Drug Administration granted first-time approval to a drug designed to treat patients suffering from spinal muscular atrophy on Dec. 23.

3-D printing, also known as "additive manufacturing," has captured increasing mainstream interest, with new breakthroughs and applications being announced all the time. While it is revolutionizing the way certain products are manufactured, 3-D printing is poised to substantively benefit the…

Pharmaceutical companies that produce or distribute highly addictive pain medications have hired dozens of Drug Enforcement Administration officials over the past decade, a Washington Post investigation reveals.

Advertisement